| The effect of standardization of insertion and removal of percutaneous left ventricular assist device J Lee, S Gondi, K Gifft, J Wang, V Bhattad, C Bavishi, PR Karuparthi, ... Cardiovascular Revascularization Medicine, 2024 | | 2024 |
| In adults with stable angina, PCI vs. a placebo procedure reduced angina symptoms at 12 wk C Bavishi Annals of Internal Medicine 177 (3), JC28, 2024 | | 2024 |
| 700.02 The Effect of Standardization of Insertion and Removal of Percutaneous Left Ventricular Assist Device J Lee, H Matsukage, S Gondi, K Gifft, J Wang, V Bhattad, C Bavishi, ... Cardiovascular Interventions 17 (4_Supplement), S62-S62, 2024 | | 2024 |
| In HF with secondary mitral regurgitation, transcatheter mitral valve repair reduced HF hospitalizations at 5 y (vol 176, pg JC77, 2023) C Bavishi ANNALS OF INTERNAL MEDICINE 176 (12), JC144-JC144, 2023 | | 2023 |
| Practice differences and knowledge gaps in complex and high-risk interventions between Japan and the USA: A case-based discussion C Bavishi, RE Davies, S Matsuno, N Kobayashi, H Katoh, K Obunai, ... Journal of Cardiology, 2023 | | 2023 |
| Harnessing Artificial Intelligence for Intravascular Imaging: Is it Percutaneous Coronary Intervention Ready? PP Sengupta, C Bavishi JACC: Advances 2 (7), 100565, 2023 | | 2023 |
| Meta-analysis assessing efficacy and safety of vitamin K antagonists versus direct oral anticoagulants for atrial fibrillation after transcatheter aortic valve implantation V Selvaraj, MS Khan, SH Mufarrih, M Kazimuddin, MA Waheed, A Tripathi, ... The American journal of cardiology 201, 260-267, 2023 | 3 | 2023 |
| In HF with secondary mitral regurgitation, transcatheter mitral valve repair reduced HF hospitalizations at 5 y C Bavishi Annals of Internal Medicine 176 (7), JC77, 2023 | | 2023 |
| In older adults with hypertension, chlorthalidone vs. hydrochlorothiazide did not reduce major CV events or deaths at 2.4 y C Bavishi Annals of Internal Medicine 176 (4), JC39, 2023 | | 2023 |
| Antihypertensive therapy reduced incident dementia vs. placebo at a median 4.3 y C Bavishi Annals of Internal Medicine 176 (3), JC33, 2023 | | 2023 |
| Statins increase muscle pain or weakness at 1 y, with an absolute excess of 11 events/1000 person-y C Bavishi Annals of Internal Medicine 176 (1), JC4, 2023 | | 2023 |
| In acute decompensated HF, adding acetazolamide to IV loop diuretics reduced congestion at 3 d C Bavishi Annals of Internal Medicine 175 (12), JC136, 2022 | | 2022 |
| Three versus 12‐month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta‐analysis of randomized … V Selvaraj, S Chatterjee, T Hirai, JD Abbott, C Bavishi Catheterization and Cardiovascular Interventions 100 (7), 1151-1158, 2022 | 4 | 2022 |
| Renal denervation in the antihypertensive arsenal-knowns and known unknowns (vol 40, pg 1859, 2022) FH Messerli, C Bavishi, J Brguljan, M Burnier, S Dobner JOURNAL OF HYPERTENSION 40 (11), 2322-2322, 2022 | | 2022 |
| Renal denervation in the antihypertensive arsenal–knowns and known unknowns FH Messerli, C Bavishi, J Brguljan, M Burnier, S Dobner, F Elijovich, ... Journal of hypertension 40 (10), 1859-1875, 2022 | 13 | 2022 |
| Implementation of robotic-assisted percutaneous coronary intervention into a high-risk PCI program KR Chitturi, S Kanake, T Nguyen, B Loc, K Baden, C Bavishi, A Kumar, ... Cardiovascular Revascularization Medicine 43, 115-119, 2022 | 3 | 2022 |
| Predictors of in-hospital de-escalation of P2Y12 inhibitors to clopidogrel in patients with acute myocardial infarction treated with percutaneous coronary intervention MU Williams, WR Lang, T Wark, G Ovide, R Mitsuyama, V Kadiyala, ... Cardiovascular Revascularization Medicine 42, 154-158, 2022 | 2 | 2022 |
| Meta-analysis of early versus delayed or selective coronary angiography in patients with out-of-hospital cardiac arrest without ST-elevation myocardial infarction C Bavishi, V Trivedi, DL Bhatt American Journal of Cardiology 175, 180-182, 2022 | 2 | 2022 |
| Does the ISCHEMIA Trial Apply to My Patients? V Upadhyaya, SN Gowda, G Porto, CP Bavishi, P Sardar, R Bashir, ... Current Cardiology Reports 24 (6), 653-657, 2022 | | 2022 |
| Why are we still prescribing angiotensin-converting enzyme inhibitors? FH Messerli, C Bavishi, S Bangalore Circulation 145 (6), 413-415, 2022 | 13 | 2022 |
Sripal BangaloreNew York University School of MedicineVerified email at nyumc.org